TY  -  
T1  - Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis : A prospective cohort study 
SN  -  /  
UR  - http://hdl.handle.net/10138/237055 
T3  -  
A1  - Aaltonen, Kalle; Heinonen, Arto; Joensuu, Jaana; Parmanne, Pinja; Karjalainen, Anna; Varjolahti-Lehtinen, Tuire; Uutela, Toini; Puurtinen-Vilkki, Maija; Arstila, Leena; Blom, Marja; Sokka, Tuulikki; Nordström, Dan 
A2  -  
PB  -  
Y1  - 2017 
LA  - eng 
AB  - Background and objectives: Tumor necrosis factor (TNF)-inhibitors are used to treat psoriatic arthritis (PsA), but only a limited number of observational studies on this subject have been published thus far. The aim of this research was to analyze the effectiveness and drug survival of TNF-inhibitors in the treatment of PsA. Methods: PsA patients identified from the National Register for Biologic Treatment in Finland (ROB-FIN) starting their first, second, or third TNF-inhibitor treatment betwee... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - Psoriatic arthritis; TNF-inhibitor; Methotrexate; Cohort study; Drug survival; Treatment response; RHEUMATOLOGY BIOLOGICS REGISTER; COLLEGE-OF-RHEUMATOLOGY; ANKYLOSING-SPONDYLITIS; CLINICAL-PRACTICE; BRITISH SOCIETY; EFFICACY; THERAPIES; METAANALYSIS; VALIDATION; CRITERIA; 3121 General medicine, internal medicine and other clinical medicine; 317 Pharmacy 
N1  -   
PP  -  
ER  -